Identification of drugs associated with reduced severity of COVID-19 - a case-control study in a large population

Ariel Israel1, Alejandro A Schäffer2, Assi Cicurel1,3

  • 1Division of Planning and Strategy, Clalit Health Services, Tel Aviv, Israel.

Elife
|July 27, 2021
PubMed

Insights

Certain cholesterol pathway medications like ubiquinone, ezetimibe, and rosuvastatin show promise in reducing COVID-19 hospitalization risk. Further research is needed to confirm these protective effects against severe coronavirus disease 2019.

Area of Science:

  • Epidemiology
  • Pharmacology
  • Public Health

Background:

  • Investigating existing medications for protective effects against severe coronavirus disease 2019 (COVID-19) is crucial due to limited accessibility of specific COVID-19 treatments.
  • A large population study was conducted within Clalit Health Services (CHS), Israel's largest healthcare provider, covering over 4.7 million members.

Purpose of the Study:

  • To identify medications acquired within the last month that decrease the risk of COVID-19 hospitalization.
  • To assess the association between medication use and reduced severity of COVID-19 outcomes.

Main Methods:

  • Two matched case-control cohorts were assembled, including adults aged 18-95 hospitalized for COVID-19 (cases).
  • Cohort 1: Five controls from the general population per case (n=6202). Cohort 2: Two non-hospitalized SARS-CoV-2 positive controls per case (n=6919).
  • Odds ratios (OR), 95% confidence intervals (CI), and p-values were calculated using Fisher's exact test, with false discovery rate adjustment for multiple testing.

Main Results:

  • Significantly reduced odds for COVID-19 hospitalization were associated with ubiquinone (OR=0.185), ezetimibe (OR=0.488), rosuvastatin (OR=0.673), flecainide (OR=0.301), and vitamin D (OR=0.869).
  • Notably, artificial tears, eye care products, and ophthalmologicals also showed a decreased risk of hospitalization.
  • Medications linked to the cholesterol synthesis pathway (ubiquinone, ezetimibe, rosuvastatin) demonstrated a protective effect.

Conclusions:

  • Ubiquinone, ezetimibe, and rosuvastatin, involved in cholesterol synthesis, were associated with lower COVID-19 hospitalization rates.
  • These findings suggest a potential protective role for these medications against severe COVID-19.
  • Further investigation in controlled, prospective studies is warranted to confirm these promising results.
Abstract

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
39
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.2K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
208
Drug Classes and Categories01:25

Drug Classes and Categories

Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.5K